Published in J Cell Biol on July 01, 1989
Flow-mediated endothelial mechanotransduction. Physiol Rev (1995) 10.13
Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest (1997) 5.77
Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J (2002) 5.44
PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol (1998) 5.21
Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol (2001) 5.17
Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer (2009) 5.02
The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol (2005) 4.54
Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin. J Cell Biol (1990) 3.81
Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol (1991) 3.38
Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med (2010) 2.88
Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol (1993) 2.81
Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest (1991) 2.70
Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A (2003) 2.66
Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol (1990) 2.65
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J (1992) 2.65
Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest (1994) 2.51
Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A (1991) 2.27
Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A (2000) 2.23
BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol (2006) 2.17
Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol (1994) 2.15
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest (1992) 2.13
Thrombospondins in cancer. Cell Mol Life Sci (2008) 2.08
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest (1990) 2.02
Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol (1990) 2.00
Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol (1997) 1.98
Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis (2003) 1.89
Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J (1990) 1.87
VE-statin, an endothelial repressor of smooth muscle cell migration. EMBO J (2003) 1.84
Transforming growth factor-beta complexes with thrombospondin. Mol Biol Cell (1992) 1.74
Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest (2007) 1.73
Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest (1995) 1.71
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J Cell Biol (1993) 1.71
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol (1993) 1.66
Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (1997) 1.65
Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis (2004) 1.62
Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch. Am J Pathol (2005) 1.60
Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol (1995) 1.58
The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci U S A (1996) 1.56
GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. Mol Cell Biol (2005) 1.54
VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med (2008) 1.54
Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest (1995) 1.52
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol (1992) 1.51
Mathematical modeling of tumor-induced angiogenesis. J Math Biol (2004) 1.51
Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol (1991) 1.50
Matrix-bound thrombospondin promotes angiogenesis in vitro. J Cell Biol (1994) 1.45
Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci U S A (1990) 1.42
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest (1994) 1.41
TGF-β - an excellent servant but a bad master. J Transl Med (2012) 1.41
Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am J Pathol (2004) 1.39
Matrix control of transforming growth factor-β function. J Biochem (2012) 1.39
Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. Am J Pathol (1994) 1.38
Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225). EMBO J (1992) 1.38
TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS One (2009) 1.38
Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. J Virol (1994) 1.36
Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity. Am J Pathol (2004) 1.34
Evolution of distinct EGF domains with specific functions. Protein Sci (2005) 1.33
In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest (1991) 1.31
Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci U S A (1994) 1.31
The latent transforming growth factor beta binding protein (LTBP) family. Biochem J (2000) 1.27
The extracellular regulation of growth factor action. Mol Biol Cell (1992) 1.25
TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis. J Oncol (2015) 1.23
Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Ann Rheum Dis (1997) 1.20
The pericyte: cellular regulator of microvascular blood flow. Microvasc Res (2009) 1.19
Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TGF-beta) by human colonic epithelial cells. Clin Exp Immunol (2000) 1.18
Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol (1993) 1.18
Extracellular fibrillar structure of latent TGF beta binding protein-1: role in TGF beta-dependent endothelial-mesenchymal transformation during endocardial cushion tissue formation in mouse embryonic heart. J Cell Biol (1997) 1.18
Dermatopontin interacts with transforming growth factor beta and enhances its biological activity. Biochem J (1999) 1.12
Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation. J Clin Invest (1996) 1.11
The mechanism for the activation of latent TGF-beta during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-beta to smooth muscle cells. J Cell Biol (1993) 1.10
Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro. Am J Pathol (1991) 1.09
Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol (1993) 1.09
The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. J Clin Invest (1994) 1.09
Differential protease expression by cutaneous squamous and basal cell carcinomas. J Clin Invest (1991) 1.09
Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol (1998) 1.07
Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration. J Cell Biol (1991) 1.07
Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol Biol Cell (1995) 1.06
Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye. EMBO J (2005) 1.06
Interplay between cell adhesion and growth factor receptors: from the plasma membrane to the endosomes. Cell Tissue Res (2009) 1.05
Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. Am J Pathol (2000) 1.05
Tumor angiogenesis: insights and innovations. J Oncol (2010) 1.04
Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS One (2013) 1.04
Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J Clin Invest (1994) 1.04
Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor. Am J Pathol (2002) 1.03
Heterotypic RPE-choroidal endothelial cell contact increases choroidal endothelial cell transmigration via PI 3-kinase and Rac1. Exp Eye Res (2006) 1.02
Understanding vascular development. Wiley Interdiscip Rev Dev Biol (2012) 1.02
Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message. J Clin Invest (1991) 1.02
SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity. J Cell Biol (2011) 1.02
Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution. Am J Pathol (1996) 1.02
Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension. J Clin Invest (1990) 1.01
Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci U S A (1994) 1.01
Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state. Am J Pathol (2007) 1.00
Micropatterned three-dimensional hydrogel system to study human endothelial-mesenchymal stem cell interactions. J Tissue Eng Regen Med (2010) 1.00
Getting Tie(2)d up in angiogenesis. J Clin Invest (2002) 1.00
Cell population dynamics modulate the rates of tissue growth processes. Biophys J (2005) 1.00
Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. Cell Mol Neurobiol (2004) 1.00
Calpain- and talin-dependent control of microvascular pericyte contractility and cellular stiffness. Microvasc Res (2010) 1.00
Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity. Am J Pathol (1995) 0.99
Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide. Biochem J (1996) 0.99
Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells. EMBO J (1991) 0.99
The role of pericyte detachment in vascular rarefaction. J Vasc Res (2014) 0.98
Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol (1987) 5.25
Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res (1977) 5.19
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol (1988) 4.34
Studies on blood capillaries. II. Transport of ferritin molecules across the wall of muscle capillaries. J Cell Biol (1968) 3.72
Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol (1987) 3.72
Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets. Proc Natl Acad Sci U S A (1984) 3.01
Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol (1987) 2.87
Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol (1984) 2.76
Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem Biophys Res Commun (1985) 2.75
Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol (1988) 2.69
Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science (1986) 2.67
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol (1987) 2.63
The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol (1986) 2.50
REGULATION OF GROWTH AND ORIENTATION IN HAMSTER CELLS TRANSFORMED BY POLYOMA VIRUS. Virology (1964) 2.41
Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch Ophthalmol (1963) 2.33
Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol (1982) 2.33
Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell (1986) 2.04
Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun (1986) 1.97
Binding of plasminogen to cultured human endothelial cells. J Biol Chem (1986) 1.87
Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem Biophys Res Commun (1986) 1.86
Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci (1966) 1.85
Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol (1970) 1.78
Further study of beta-TGFs released by virally transformed and non-transformed cells. Int J Cancer (1985) 1.77
Binding and activation of plasminogen on the platelet surface. J Biol Chem (1985) 1.76
Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest (1983) 1.75
The difference in contact inhibition of cell replication between normal cells and cells transformed by different carcinogens. Proc Natl Acad Sci U S A (1966) 1.59
Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1. Cancer Res (1987) 1.59
Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost (1987) 1.43
The role of membrane-membrane interactions in the regulation of endothelial cell growth. J Cell Biol (1985) 1.41
Studies on protein passage through arterial endothelium. I. Structural correlates of permeability in rat arterial endothelium. Lab Invest (1973) 1.37
Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface. J Cell Biol (1987) 1.33
Pericytes in diabetic retinopathy. Br J Ophthalmol (1966) 1.24
Maintenance of integrity in aortic endothelium. Fed Proc (1980) 1.20
Species specificity in growth regulatory effects of cellular interaction. Nature (1968) 1.12
Junctional transfer of small molecules in cultured bovine brain microvascular endothelial cells and pericytes. Microvasc Res (1987) 1.11
Gap junctions in arterial endothelium. J Cell Biol (1973) 1.10
Inhibition of endothelial cell regrowth. Cessation of aortic endothelial cell replication after balloon catheter denudation. Arteriosclerosis (1982) 1.07
Fracture faces of fenestrations and junctions of endothelial cells in human choroidal vessels. Invest Ophthalmol (1975) 1.05
Morphometric analysis of gap junctions in regenerating arterial endothelium. Lab Invest (1982) 1.03
Cytoplasmic transfer between endothelium and lymphocytes: quantitation by flow cytometry. Am J Pathol (1988) 0.99
Roles of cell-to-cell communication in development. Biol Reprod (1985) 0.92
Ultrastructure of infantile hemangioendothelioma of the liver. Cancer (1978) 0.92
The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain. J Biol Chem (1984) 0.88
The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell (1999) 11.59
An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem (1994) 6.31
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
Biology and biochemistry of proteinases in tumor invasion. Physiol Rev (1993) 4.17
Biological roles of fibroblast growth factor-2. Endocr Rev (1997) 3.57
Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell (1986) 3.42
Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol (1988) 3.16
Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol (1998) 3.12
Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol (1988) 2.84
Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int (1997) 2.82
Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol (1988) 2.69
Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol (1990) 2.65
Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci U S A (1986) 2.62
Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol (1990) 2.33
Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol (1982) 2.33
Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci U S A (1991) 2.27
Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Mol Biol Cell (1998) 2.26
Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol (1992) 2.08
In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol (1989) 2.05
The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol (1987) 2.04
Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol (1997) 1.98
Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol (1986) 1.94
TGF-beta latency: biological significance and mechanisms of activation. Stem Cells (1997) 1.91
Both normal and tumor cells produce basic fibroblast growth factor. J Cell Physiol (1986) 1.91
Transformation of rat embryo fibroblasts by cloned polyoma virus DNA fragments containing only part of the early region. Proc Natl Acad Sci U S A (1980) 1.89
Properties of plasminogen activators formed by neoplastic human cell cultures. J Exp Med (1974) 1.88
Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta (1988) 1.82
Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med (1990) 1.80
Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol (1990) 1.75
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells. J Cell Biol (1993) 1.71
Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol (1988) 1.69
A form of human basic fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Commun (1987) 1.69
Proteolytically derived fragments of human plasma fibronectin and their localization within the intact molecule. J Biol Chem (1980) 1.68
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol (1993) 1.66
Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res (1990) 1.59
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem (1994) 1.58
A specific labeling procedure for proteins on the outer surface of membranes. J Biol Chem (1972) 1.55
Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner. Proc Natl Acad Sci U S A (1991) 1.52
Characterization of latent TGF-beta activation by murine peritoneal macrophages. J Immunol (1995) 1.52
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol (1992) 1.51
Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology (1971) 1.49
Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Lab Invest (1989) 1.48
Tumor promoters induce changes in the chick embryo fibroblast cytoskeleton. Cell (1979) 1.47
Requirement for the large T and small T proteins of SV40 in the maintenance of the transformed state. Cold Spring Harb Symp Quant Biol (1980) 1.43
Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol (1990) 1.42
Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci U S A (1983) 1.42
Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein (1996) 1.42
Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol (1989) 1.42
Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci U S A (1990) 1.42
Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-beta binding protein-1 that mediates bonding to the latent transforming growth factor-beta1. J Biol Chem (1996) 1.40
Early mutants of polyoma virus (dl8 and dl23) with altered transformation properties: is polyoma virus middle T antigen a transforming gene product? Cold Spring Harb Symp Quant Biol (1980) 1.39
Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. Proc Natl Acad Sci U S A (1987) 1.39
Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells. J Cell Biol (1990) 1.37
Transformation of primary hamster brain cells with JC virus and its DNA. J Virol (1980) 1.36
Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells. Cell (1980) 1.35
In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor. Dev Biol (1988) 1.32
Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta. J Cell Physiol (1994) 1.32
FGF suppresses apoptosis and induces differentiation of fibre cells in the mouse lens. Development (1995) 1.31
Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell (1993) 1.31
Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression. J Cell Physiol (1999) 1.30
Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan. J Cell Physiol (1989) 1.30
Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms. J Cell Biol (1995) 1.30
High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc Natl Acad Sci U S A (1993) 1.29
Selective lysis of cells transformed by Rous Sarcoma virus. Virology (1971) 1.29
The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol (1991) 1.29
Activation of latent transforming growth factor beta. Adv Pharmacol (1993) 1.26
The extracellular regulation of growth factor action. Mol Biol Cell (1992) 1.25
The organization of the proteins of vesicular stomatitis virions: labeling with pyridoxal phosphate. Virology (1975) 1.23
Extracellular microfibrils in development and disease. Cell Mol Life Sci (2007) 1.21
Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood (1993) 1.19
Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res (1999) 1.14
The latent transforming growth factor-beta-binding protein-1 promotes in vitro differentiation of embryonic stem cells into endothelium. Mol Biol Cell (2000) 1.14
Transforming growth factor-beta 1 regulates axon/Schwann cell interactions. J Cell Biol (1995) 1.14
Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol (1992) 1.13
Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan. J Cell Biol (1991) 1.13
Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution. Mol Biol Cell (1996) 1.12
Extracellular matrix regulation of growth factor and protease activity. Curr Opin Cell Biol (1991) 1.12
Production of plasminogen activator by established cell lines of mouse origin. J Cell Biol (1977) 1.11
Studies of Rous sarcoma virus. Effects of nucleoside analogues on virus synthesis. J Biol Chem (1973) 1.11
Bone defects in latent TGF-beta binding protein (Ltbp)-3 null mice; a role for Ltbp in TGF-beta presentation. J Endocrinol (2002) 1.10
Release of GPI-anchored membrane proteins by a cell-associated GPI-specific phospholipase D. EMBO J (1994) 1.10
Down-regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells. Proc Natl Acad Sci U S A (1983) 1.10
The development of a quantitative RIA for basic fibroblast growth factor using polyclonal antibodies against the 157 amino acid form of human bFGF. The identification of bFGF in adherent elicited murine peritoneal macrophages. J Immunol Methods (1988) 1.07
A wound healing model using healing-impaired diabetic mice. J Dermatol (1992) 1.07
Lipoprotein (a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration. J Cell Biol (1991) 1.07
Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell Regul (1991) 1.07
Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2. J Biol Chem (2000) 1.07
Virus-induced modification of cellular membranes related to viral structure. Annu Rev Microbiol (1974) 1.06
Isolation of a protease inhibitor from tissues resistant to tumor invasion. Hoppe Seylers Z Physiol Chem (1977) 1.06
Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol (1991) 1.06
Transformation by basic fibroblast growth factor requires high levels of expression: comparison with transformation by hst/K-fgf. Oncogene Res (1989) 1.05
Isolation and characterization of ribonucleoprotein substructures from Rous sarcoma virus. Virology (1972) 1.05
The presence of two major hemoglobin components in an inbred strain of mice. Proc Natl Acad Sci U S A (1966) 1.04
Stimulation of motility in cultured bovine capillary endothelial cells by angiogenic preparations. J Cell Physiol (1984) 1.04
SV40 mutants with an altered small-t protein are tumorigenic in newborn hamsters. Virology (1981) 1.02
Lipid studies of Rous sarcoma virus and host cell membranes. Virology (1972) 1.02